Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mulligan

Showing results (261-270 of 364) with videos related to

Pageof 37
Sort By:
American Journal of Clinical Oncology|January 22, 2024
Disparities in the Receipt of Systemic Treatment in Metastatic MelanomaHanna Kakish, Omkar Pawar, Maira Bhatty, et al.
Human Molecular Genetics|June 1, 1994
A de novo mutation of the RET proto-oncogene in a patient with MEN 2AL M Mulligan, C Eng, C S Healey, et al.
World Neurosurgery|December 5, 2021
The 2021 Neurosurgery Match: An Analysis of the Impact of Virtual Interviewing and Other COVID-19-Related ChangesKathleen M Mulligan, Xuankang Pan, Christina Gerges, et al.
Journal of the American Academy of Dermatology|August 9, 2022
From the Cochrane library: Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settingsKathleen M Mulligan, Katie A O'Connell, Alexandra da Silva, et al.
Clinical and Experimental Dermatology|October 6, 2021
Online crowdfunding for medical expenses related to hidradenitis suppurativaD X Zheng, K M Mulligan, B Gallo Marin, et al.
JAMA|October 11, 1995
Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type IIH P Neumann, C Eng, L M Mulligan, et al.
Pediatric Dermatology|August 25, 2022
Delayed medical care due to transportation barriers among US children with atopic dermatitisDavid X Zheng, Thomas B Cwalina, Kathleen M Mulligan, et al.
American Journal of Medical Genetics|March 1, 1987
Recombination between the factor VIII gene and the DXS52 locus gives the most probable genetic order as centromere-fra(X)-DXS15-DXS52-F8C-telomereL M Mulligan, H J Grover, V S Blanchette, et al.
Clinical and Experimental Dermatology|March 14, 2023
Current landscape of clinical trials for vitiligo: improving outcome standardization and trial diversityKathleen M Mulligan, Katie A O'Connell, Madeline S Coleman, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|April 1, 1994
[Mutations of RET proto-oncogene in Hirschsprung disease]S Lyonnet, P Edery, L M Mulligan, et al.
Pageof 37

Showing results (261-270 of 364) with videos related to

Sort By:
Pageof 37
American Journal of Clinical Oncology|January 22, 2024
Disparities in the Receipt of Systemic Treatment in Metastatic MelanomaHanna Kakish, Omkar Pawar, Maira Bhatty, et al.
Human Molecular Genetics|June 1, 1994
A de novo mutation of the RET proto-oncogene in a patient with MEN 2AL M Mulligan, C Eng, C S Healey, et al.
World Neurosurgery|December 5, 2021
The 2021 Neurosurgery Match: An Analysis of the Impact of Virtual Interviewing and Other COVID-19-Related ChangesKathleen M Mulligan, Xuankang Pan, Christina Gerges, et al.
Journal of the American Academy of Dermatology|August 9, 2022
From the Cochrane library: Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settingsKathleen M Mulligan, Katie A O'Connell, Alexandra da Silva, et al.
Clinical and Experimental Dermatology|October 6, 2021
Online crowdfunding for medical expenses related to hidradenitis suppurativaD X Zheng, K M Mulligan, B Gallo Marin, et al.
JAMA|October 11, 1995
Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type IIH P Neumann, C Eng, L M Mulligan, et al.
Pediatric Dermatology|August 25, 2022
Delayed medical care due to transportation barriers among US children with atopic dermatitisDavid X Zheng, Thomas B Cwalina, Kathleen M Mulligan, et al.
American Journal of Medical Genetics|March 1, 1987
Recombination between the factor VIII gene and the DXS52 locus gives the most probable genetic order as centromere-fra(X)-DXS15-DXS52-F8C-telomereL M Mulligan, H J Grover, V S Blanchette, et al.
Clinical and Experimental Dermatology|March 14, 2023
Current landscape of clinical trials for vitiligo: improving outcome standardization and trial diversityKathleen M Mulligan, Katie A O'Connell, Madeline S Coleman, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|April 1, 1994
[Mutations of RET proto-oncogene in Hirschsprung disease]S Lyonnet, P Edery, L M Mulligan, et al.
Pageof 37